A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer-论文-万方医学网

A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer

导出原文传递

翻译打印收藏纠错

作者： Metzger Filho, Otto ^[1] ; Giobbie-Hurder, Anita ^[2] ; Lin, Nancy U. ^[3] ; Faggen, Meredith ^[4] ; Come, Steven ; Openshaw, Thomas ; Constantine, Michael ; Walsh, Jeanna ; Freedman, Rachel A. ; Schneider, Bryan ; Burstein, Harold J. ; Mayer, Erica L.

作者单位： Dana Farber Canc Inst, Boston, MA 02115 USA ^[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA ^[2] Eastern Maine Med Ctr, Bangor, ME USA ^[3] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA ^[4]

关键词 Breast cancer Eribulin Adverse event CTCAE PRO-CTCAE

发布时间 2022-09-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除